About Puray
Hospital-acquired infections are among the most pressing problems in healthcare. According to Germany’s RKI, 10,000–20,000 patients die annually from infections acquired in hospitals. Infections caused by multidrug-resistant pathogens are a particular challenge. One of the most common forms of hospital-acquired infection is “device-associated infection.” These occur when pathogens enter the body via medical tubes, such as catheters or probes. Device-associated infections rank among the most frequent, costly, and dangerous forms of hospital-acquired infections. Puray is developing a medical catheter that actively prevents hospital-acquired infections. Our product emits UVC light at a specific wavelength that kills pathogens without damaging human cells. For the first time, this enables the catheter to be safely and continuously disinfected during use, protecting patients from infections. The technology reduces the need for antibiotics and remains effective even against multidrug-resistant pathogens. We aim to apply our innovation to other medical tubes in the future, such as ventilation tubes, cardiac catheters, and vascular catheters, thereby preventing a large proportion of all hospital-acquired infections.
Discover relevant articles, startups, and events from the ecosystem
Online: Holding structures: Implementation and benefits for startups
